These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1420623)

  • 21. Effect of caffeine on cerebral blood flow velocity in preterm infants.
    Saliba E; Autret E; Gold F; Bloc D; Pourcelot L; Laugier J
    Biol Neonate; 1989; 56(4):198-203. PubMed ID: 2529912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: a component of the synthetic surfactant Exosurf.
    Thomassen MJ; Antal JM; Divis LT; Wiedemann HP
    Clin Immunol Immunopathol; 1995 Nov; 77(2):201-5. PubMed ID: 7586728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
    Levine D; Edwards DK; Merritt TA
    AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant inhibits cationic liposome-mediated gene transfer.
    Tsan MF; Tsan GL; White JE
    Hum Gene Ther; 1997 May; 8(7):817-25. PubMed ID: 9143907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant and respiratory distress syndrome.
    Milner AD
    Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Criteria for use of colfosceril (Exosurf) in neonates.
    Bhatt-Mehta V; Schumacher RE
    Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
    [No Abstract]   [Full Text] [Related]  

  • 28. Surface tension of therapeutic surfactants (exosurf neonatal, infasurf, and survanta) as evaluated by standard methods and criteria.
    Scarpelli EM; David E; Cordova M; Mautone AJ
    Am J Perinatol; 1992; 9(5-6):414-9. PubMed ID: 1418146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant therapy in respiratory distress syndrome--the first local experience.
    Lim NL; Nordin MM; Cheah IG
    Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of three surfactant preparations on in vitro lymphocyte functions.
    Woerndle S; Bartmann P
    J Perinat Med; 1994; 22(2):119-28. PubMed ID: 7965541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of exogenous surfactant on the development of surfactant synthesis in premature rabbit lung.
    Amato M; Petit K; Fiore HH; Doyle CA; Frantz ID; Nielsen HC
    Pediatr Res; 2003 Apr; 53(4):671-8. PubMed ID: 12612208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosurf enhances adenovirus-mediated gene transfer to alveolar type II cells.
    Manuel SM; Guo Y; Matalon S
    Am J Physiol; 1997 Oct; 273(4):L741-8. PubMed ID: 9357848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome.
    Seppänen M; Kääpä P; Kero P
    Am J Perinatol; 1994 Nov; 11(6):382-5. PubMed ID: 7857426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse experiences in an Exosurf treated group.
    Chatfield SL; Kelly EJ; Dear PR
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F78. PubMed ID: 8117137
    [No Abstract]   [Full Text] [Related]  

  • 37. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect.
    Van Bel F; Van de Bor M; Stijnen T; Baan J; Ruys JH
    Pediatrics; 1989 Nov; 84(5):802-7. PubMed ID: 2677960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL
    Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbon dioxide reactivity of the cerebral circulation in extremely premature infants: effects of postnatal age and indomethacin.
    Levene MI; Shortland D; Gibson N; Evans DH
    Pediatr Res; 1988 Aug; 24(2):175-9. PubMed ID: 3141892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of indomethacin on cerebral blood flow velocity of premature newborns.
    Laudignon N; Chemtob S; Bard H; Aranda JV
    Biol Neonate; 1988; 54(5):254-62. PubMed ID: 3203119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.